AIFM1 and Cerebral ischemia: Targeting the PAR/AIF pathway, Danhong injection, astragaloside IV and baicalein inhibited parthanatos, eliminated neurological dysfunction and ameliorated cerebral ischemia injury in vivo and in vitro [148–150].